Trials / Completed
CompletedNCT00581451
Study Evaluating the Tolerability of Bifeprunox in Healthy Subjects
A 3-Part, Randomized, Multiple-Dose, Sequential Design Study of Bifeprunox in Healthy Subjects in Order to Establish a Titration Regimen With an Improved Tolerability Profile
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 144 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Safety and tolerability study in healthy volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bifeprunox | oral tablet once daily |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2007-12-27
- Last updated
- 2009-07-10
Source: ClinicalTrials.gov record NCT00581451. Inclusion in this directory is not an endorsement.